ICL to Acquire Lavie Bio in Strategic Ag Tech Move

ICL has signed a definitive agreement to acquire Lavie Bio, a subsidiary of Evogene Ltd., focusing on microbiome-based agricultural products. The transaction, expected to close in Q2 2025, aims to enhance ICL’s capabilities in ag-biologicals and follows over two years of collaboration between the companies.

Original excerpt: ICL will also acquire Evogene’s MicroBoost AI for AG platform…

Source: AgriBusiness Global